Validation Study of Kim's Sham Needle by Measuring Facial Temperature: An N-of-1 Randomized Double-Blind Placebo-Controlled Clinical Trial

被引：5
|
作者：
Lee, Sanghun [1 ]
Lim, Nara [2 ]
Choi, Sunmi [1 ]
Kim, Sungchul [2 ]
机构：
[1] Korea Inst Oriental Med, Res Ctr, Div Standard Res Acupuncture Moxibust & Meridi, Taejon, South Korea
[2] Wonkwang Univ, Oriental Med Hosp, Dept Acupuncture & Moxibust, Kwangju, South Korea
来源：
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE | 2012年 / 2012卷
关键词：
BLOOD-FLOW; SMOKING;
D O I：
10.1155/2012/507937
中图分类号：
R [医药、卫生];
学科分类号：
10 ;
摘要：
Introduction. In 2008, Kim's sham needle was developed to improve the quality of double-blinded studies. The aim of this study is to validate Kim's sham needle by measuring facial temperature. Methods. We designed "N-of-1" trials involving 7 smokers. One session was composed of 2 stimulations separated by a 2 h washout period. Six sessions were applied daily for all subjects. Infrared thermal imaging was used to examine the effects of acupuncture (HT8, KI2) on facial temperature following smoking-induced decrease. Results. All subjects demonstrated decreased temperatures after sham needle treatment, but 5 of the 7 subjects showed increased temperatures after real needle treatment. 6 of the 7 subjects showed a significant difference (P < 0.05) between treatments with real and sham needles. Thus, the physiological stimulation of Kim's sham needle is different from that of a real needle, suggesting that Kim's sham needle is a potential inactive control intervention.
引用
收藏
页数：7
相关论文
共 50 条
  • [21] Lack of efficacy of oral N-acetylcysteine in the treatment of facial melasma in women: a randomized, double-blind, placebo-controlled clinical trial
    Alfredo, Melissa de Almeida Correa
    Holanda, Ingrid Rocha Meireles
    Cassiano, Daniel Pinho
    Esposito, Ana Claudia Cavalcante
    Lima, Paula Basso
    Miot, Helio Amante
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2024, 99 (06) : 928 - 931
  • [22] Randomized clinical trial: rikkunshito in the treatment of functional dyspepsiaa multicenter, double-blind, randomized, placebo-controlled study
    Suzuki, H.
    Matsuzaki, J.
    Fukushima, Y.
    Suzaki, F.
    Kasugai, K.
    Nishizawa, T.
    Naito, Y.
    Hayakawa, T.
    Kamiya, T.
    Andoh, T.
    Yoshida, H.
    Tokura, Y.
    Nagata, H.
    Kobayakawa, M.
    Mori, M.
    Kato, K.
    Hosoda, H.
    Takebayashi, T.
    Miura, S.
    Uemura, N.
    Joh, T.
    Hibi, T.
    Tack, J.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2014, 26 (07): : 950 - 961
  • [23] N-ACETYLCYSTEINE IN CHILDREN WITH AUTISM: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Gray, K. M.
    Dean, O. M.
    Villagonzalo, K.
    Dodd, S.
    Mohebbi, M.
    Vick, T.
    Tonge, B. J.
    Berk, M.
    JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2015, 59 (09) : 790 - 791
  • [24] The clinical effect of benesco™ on reflux symptoms: A double-blind randomized placebo-controlled trial
    Kuipers, Thijs
    Oude Nijhuis, Renske A. B.
    Schuitenmaker, Jeroen M.
    Bredenoord, Albert J.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2023, 35 (10):
  • [25] Safety and Efficacy of Levamisole in Loiasis: A Randomized, Placebo-controlled, Double-blind Clinical Trial
    Campillo, Jeremy T.
    Bikita, Paul
    Hemilembolo, Marlhand
    Louya, Frederic
    Missamou, Francois
    Pion, Sebastien D. S.
    Boussinesq, Michel
    Chesnais, CedricB
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) : 19 - 27
  • [26] A randomized, double-blind, placebo-controlled clinical trial of itraconazole in the treatment of cutaneous leishmaniasis
    Nassiri-Kashani, M
    Firooz, A
    Khamesipour, A
    Moitahed, F
    Nilforoushzadeh, M
    Hejazi, H
    Bouzari, N
    Dowlati, Y
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2005, 19 (01) : 80 - 83
  • [27] HSDD, Flibanserin, and Eye Dynamics: A Double-Blind Randomized Placebo-Controlled Clinical Trial
    Cacioppo, Stephanie
    Kaske, Erika
    Siewsrichol, Wasuwat
    Millheiser, Leah
    OBSTETRICS AND GYNECOLOGY, 2019, 133 : 101S - 101S
  • [28] Atorvastatin Treatment For Pulmonary Sarcoidosis, A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Fontana, J. R.
    Moss, J.
    Stylianou, M.
    Levine, S. J.
    Barochia, A. V.
    Weir, N.
    Parrish, S.
    Lazarus, A.
    Nations, J. A.
    McKay, S.
    Browning, R.
    MacDonald, S.
    May, R.
    Haughey, M.
    McGraw, P.
    Barton, M.
    Guerriero, M.
    Jolley, C.
    Folio, L. R.
    Siegelman, J.
    Kaneshiro, R.
    Bea, V. Jolley
    Bahrami, G.
    Manganiello, V. C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [29] THE CLINICAL EFFECT OF BENESCOTM ON REFLUX SYMPTOMS: A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED TRIAL
    Kuipers, Thijs
    Berndien, Renske Anne
    Nijhuis, Oude
    Schuitenmaker, Jeroen M.
    Bredenoord, Arjan
    GASTROENTEROLOGY, 2023, 164 (06) : S586 - S586
  • [30] A randomized, double-blind, placebo-controlled clinical trial of rifampicin in multiple system atrophy
    Gilman, S.
    Low, P. A.
    Robertson, D.
    Bioggioni, I.
    Freeman, R.
    Kaufmann, H.
    Perlman, S.
    Hauser, R. A.
    Cheshire, W. P.
    Lessig, S. L.
    Vernino, S.
    MOVEMENT DISORDERS, 2012, 27 : S379 - S380
12345